drugset
drugset / Trial / NCT01441869

Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc

NCT01441869 ↗

Phase 1 Completed 28 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

Study in healthy subjects to measure amount of drug in blood after dosing with different saxagliptin / metformin products.

Timeline

Start
2011-10
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral
Subject Metformin Small molecule 1000 mg Oral
Subject SAXAGLIPTIN ANHYDROUS Small molecule 5 mg Oral

Indications

No indication recorded.